Introduction
During the current investigation, we have used the Moloney Murine Leukemia Virus -temperature sensitive mutant (MoMuLVts1) to induce lymphoma, by maternally transmitted retrovirus infection via breast milk in mice. Our laboratory is the first to show the development of lymphoma among the offspring of ts1 infected mothers. Lymphoma induction by integration of the Moloney Murine Leukemia Virus (MoMuLV) genome into the mouse genome has been demonstrated by a number of investigators (Hwang et al., 2002; Johnson et al., 2005; Joosten et al., 2002; Kim et al., 2003; Lund et al., 2002; Mikkers et al., 2002; Sorensen et al., 1996; Suzuki et al., 2002) . Induction of lymphoma by MoMuLV is a multistep process driven by both viral and non-viral mechanisms Hartley et al., 1997) . Although provirus integration is random in virus infected nontumor cells, it shows regional specificity in these lymphomas, suggesting that insertional mutagenesis may play an important role in tumor induction and progression. MoMuLV, unlike transforming viruses, lacks oncogenes and employs mechanisms such as promoter insertion and enhancer activation to induce tumors. MoMuLV infection activates Rel/NF-kB transcription factor, (Pak and Faller, 1996) which may participate in induction of lymphoma. Several other viruses, such as human immunodeficiency virus 1 (HIV-1) and cytomegalovirus, activate NF-kB (Bachelerie et al., 1991; Cherrington and Mocarski, 1989) . Existing literature shows that lymphomas associated with MoMuLV are clonal tumors and appear four to six months following virus inoculation. The proviral integration form of the retrovirus is generally located near an appropriate cellular protooncogene in tumor cells. Activation of the proto-oncogenes causes pathological changes in specific cell types leading to clonal expansion of the infected cell producing cancer (Kim et al., 2003) . Targeted genes have been shown to play an important role in oncogenesis (Neel et al., 1981; Nusse and Varmus, 1982; Rosenberg and Jolicoeur, 1997) . PCR and RT-PCR-based methods were used by Paun et al. (2005) and by Shin et al. (2004) for LP-BM5 and ecotropic MuLV in C57 BL/6J, AKR and C58 mice respectively. Positions of provirus/host DNA junctions were identified by PCR-based techniques in murine tumors using SL3-3 retrovirus in T-cell lymphomas (Rasmussen et al., 2005) . According to Kim et al. (2003) , candidate cancer genes in mouse T-cell lymphomas induced by SL3-3 retrovirus include transcription factors, such as Fos, Gfi1, Lef1, Myb, Myc, Runx3 and Sox3, all three D cyclins and Ras signaling pathway factors, including Rras 2/TC 21, Rasgrp 1 and Cmkbr7/CC R7. Rras 2 was the most frequent target with increased expression observed in insertions as far as 57 kb from the transcribed region. This study justified the importance of genome-based analysis of retroviral integration for identification of new cancer genes and their potential role in human cancer. Suzuki et al. (2002) identified 884 retroviral integration sites (RIS) in B-cell lymphomas in their mouse model using retroviral tagging for gene discovery by inverse-PCR (I-PCR), DNA sequencing and bioinformatics tool provided by Mouse Genome Project. These authors located 36 common retroviral integration sites (CIS) that are known or predicted to be genes involved in human cancer or their homologs. This approach has been extremely powerful for identification of a large number of genes for different diseases (Suzuki et al., 2002) . Shin et al. (2004) located 62 common integration sites including 31 previously identified sites. Seven new sites were identified in marginal zone lymphoma (MZL) of NFS.V+ mice. They found differential patterns of gene expression and disease progression for Gfi1, Sox4, Brca2, Snf1lk, Nfkb1, Pou2af1, Prdm1, Stat6 and Blnk by using microarrays and qRT-PCR. Hansen et al. (2000) and Li et al. (1999) identified target genes and several candidate cancer genes. They demonstrated that genome-based analysis of retroviral insertion sites for identification of specific cancer candidate genes is a highly powerful technique. Identification of large numbers of candidate cancer genes is possible by analysis of retroviral common integration sites in tumors based on the mouse genome sequence (Kim et al., 2003; Li et al., 1999; Suzuki et al., 2002) .
MoMULV-ts1 is an excellent model for studying the molecular mechanism of lymphoma development through natural transmission of a retrovirus via breast milk to the offspring of infected mothers, and their progression through clinical stages. Typically 100% of mice infected with wildtype MoMuLV develop lymphoma (Fan. 1997 ). In our model, about 13-15% of offspring developed lymphoma, thus providing an excellent control system. The pups of the same litter had a 100% infection rate, but with or without the lymphoma. Using this model, we have identified 29 target genes by inverse-PCR (I-PCR) for viral integration that could be candidate genes involved in lymphoma development. This model is interesting since no clear evidence is available to date on breast milk transmitted virus induced lymphomagenesis. Although Epstein-Barr virus (EBV) (Fan et al., 2005) has been implicated in lymphoma development in HIV infected patients, no conclusive evidence of the carcinogenicity of this virus has been presented thus far. Non-Hodgkins lymphoma is an AIDS defining illness. However, there is no direct established relationship between HIV infection and development of lymphoma. Although several investigators have reported that HIV-1 integration into host cells causing T-cell lymphoma, further studies are needed to understand the effect of HIV on lymphoma development. For example, HIV integration was reported within fur gene at upstream of c-fes/fps proto-oncogene causing T-cell lymphoma (Shiramizu et al., 1994) . Additionally, integration of HIV-1 in T-lymphocytes has been shown to cause malignant transformation leading to lymphoma (Herndier et al., 1992) . In other studies, tax gene has been shown to immortalize Tlymphocytes and cause T-cell lymphoma by human T-cell leukemia virus (HTLV-1) (Jeng et al., 2004 and Blattner, 1999) . It must be noted that HIV-1 infection causes considerable increase in cancer burden through multiple mechanisms. Therefore, a retroviral model for cancer induction needs careful investigation and our model will help provide information regarding the relationship between retroviral infection and lymphomagenesis.
Results
Lymphoma development in offspring of uninfected and infected mothers via breast milk of infected biological and surrogate mothers Nine control pups born to control mothers (DMEM injected) were suckled from surrogate control mothers, none of which had ts1 infection or lymphoma (Group 1). None of the 46 pups from infected mothers developed lymphoma when suckled from uninfected surrogate mothers (Group 2), although 78% of these pups tested positive for ts1. Thirteen pups which developed lymphoma were from three different experimental conditions: two of 29 pups from infected mothers that suckled from infected surrogate mothers developed lymphoma (Group 3). Six of 38 control pups from uninfected mothers developed lymphoma when they were allowed to suckle from infected surrogate mothers (Group 4). Five of 24 pups from infected mothers developed lymphoma when they suckled from their ts1 infected biological mothers (Group 5) ( Table 1) .
Identification of proviral genome integration sites by inverse-PCR (I-PCR)
Spleen and lymph node tissues were used for this study in determining viral integration sites. Tissues from uninfected pups suckled from uninfected control mothers were used to obtain baseline values for fold change in gene expression levels but not for determining viral integration sites. Tissues from infected pups with lymphoma (LYM) and pups with no lymphoma (N LYM) were used for identification of viral integration sites. Of 720 colonies screened, 368 were white colonies indicating the insertion of viral genome into the murine genome and applied towards further analysis. Of these 368 colonies 209 proviral genomic insertion sites were found (Table 2) . Fifty-two were intragenic and 157 were intergenic sites with over 90 unique intra and intergenic combined viral integration sites identified in mouse genome (Table 3 ). The maximum number of insertion sites (N10) were found in chromosomes 1, 2, 5, 7, 10, 11, 12 and 13, with the most on chromosomes 10, 12 and 13 with 26, 32 and 45 insertions, respectively ( Fig. 1) . Interestingly, of all 45 inserts in chromosome 13, 39 were at the same location from one animal and none of the animals showed viral inserts in 18 or Y chromosomes (Fig. 1 ).
The mRNA expression of candidate genes in spleens of control mice and mice with lymphoma Twenty-nine genes were selected for mRNA analysis by examining the effect of viral integration on their expression level based on 1) their proximity to specific genes (within 100 kb); 2) listing in Retroviral Tagged Cancer Gene Database (http://RTCGD.ncifcrf.gov) for genes associated with cancer in relation to retroviral insertions; 3) their association with cancer development. The change in mRNA expression has been depicted in Table 4a and 4b and summarized in Fig. 2 . The expression values of 29 genes examined included 11 candidate genes with intragenic VIS (viral integration site) (Table 4a) and 18 candidate genes with intergenic VIS (Table 4b ).
mRNA expression levels for genes interrupted by VIS (intragenic) or adjacent to VIS (intergenic) were examined in mice. The fold change of mRNA expression level compared to control group ranged from 0.10 for Ifng to 19.48 for Gfi1 (Table 4a -clear boxes). The mRNA expression of Tacc3 and Aurka genes with intergenic VIS was found to undergo the most upregulation with averages of 9.2 and 2-fold increases in mRNA expression respectively compared to controls. Gfi1 showed the highest levels of mRNA expression with a 19.48-fold increase in LYM1. Among other animals of this group (LYM), an average of 7.1-fold upregulation was noted compared to the control group. Gfi1 may be a marker of clinical significance because when the value of LYM1 (19.48), an outlier, was removed the standard deviation changed from borderline significance at p b 0.06 to 0.002 (significant). Ahi1 with intragenic VIS also showed significant increases in mRNA expression levels with an average of 3.8-fold upregulation compared to the control mice. The mRNA expression showed a 3.4-fold upregulation in LYM1, a 4.5-fold increase in LYM5 and a 7.8-fold increases in LYM6. All samples from the lymphoma group for Tacc3 showed a range of 2.7-fold to 17.4-fold increases in expression when compared to control group. LYM5 showed 17.4-fold increase and LYM6 showed 16.1-fold increase. Similarly, a 2.59-fold upregulation of mRNA for Aurka in LYM5 was observed. Other members of the same lymphoma group showed increases of Aurka ranging from 1.08 to 2.2-fold compared to the control group. Table 5 shows the detail descriptions of these 29 genes, the insertion sites, mouse and human chromosome location and gene functions.
Discussion
Although extensive investigations have been carried out on development of lymphoma using Moloney Murine Leukemia Virus (MoMuLV), so far no study is available on MoMuLV-ts1 (temperature sensitive) virus causing lymphoma among offspring of ts1 infected females. Specifically, available literature does not address viral transmission causing lymphoma via breast milk from biological or surrogate infected mothers to the offspring. In our previous investigation we have reported that breast milk is a major source of ts1 infection among offspring of BALB/c mice (Duggan et al., 2004; Duggan et al., 2006) . Transmission of retrovirus via breast milk is important, since transmission of HIV through breast milk is a major source of infection for mother-to-child transmission (MTCT) in humans (De Cock et al., 2000) . Although Naarding et al. (2005) reported the beneficial effect of Lewis X (Le x ), a sugar epitope in human breast milk and proposed that binding of Le x to DC-SIGN may reduce the HIV transmission to the infants breast fed by infected mothers, there is no doubt that breastfeeding is the major route of HIV transmission to babies of mothers with HIV infection (Coutsoudis et al., 2004) . More work is needed regarding how specific molecules, such as Le x in breast milk can be used to deter the entry of pathogenic microorganisms into the cells. Many studies have shown that once a virus such as EBV enters the cell and the viral genes insert into the host DNA, the host genome becomes altered leading to malignancies (Fan et al., 2005; J. Li et al., 1999; Liao et al., 1995; Scheijen et al., 1997; Shin et al., 2004) . Many of these genes produce proteins which are responsible for causing various types of cancer. In this report, we have shown that the insertion of ts1 viral genome into the infected pups is associated with lymphoma. MoMuLV typically induces T-cell lymphoma in 100% of the infected mice with a mean latency period of 3-4 months (Fan, 1997 Fan (1997) , the role of activated proto-oncogenes for tumorigenesis is a multistep process, similar to humans and important insight can be obtained from the MoMuLV studies.
We have observed distribution of VIS throughout the entire mouse genome with no preferred sites except one on chromosome 13 with 39 hits in LYM6 mouse. This suggests that viral integration into the mouse genome is random, similar to that reported for the HIV integration into the human genome (Lewinski et al., 2006) . Only two VIS out of nearly 90 were identified in both groups, i.e. mice with lymphoma and mice without lymphoma, suggesting that these two groups may be distinct and that some VIS are not relevant in the development of lymphoma while other VIS are involved in lymphoma development. This suggests that lymphoma development is a random event, developing only when certain sites were targeted for viral genome integration. This fits well with the hypothesis that viral integration will lead to lymphoma development only when it occurs in areas near genes related to lymphoma development. Several genes may be especially good candidates for lymphoma development. Expression patterns on Tacc3 and Gfi1 genes were similar in mice with lymphoma revealing upregulation for these genes, though to Fig. 1 . This is a graphical representation, showing the MoMuLV-ts1 insertion sites on mouse chromosomes. This is a representative summary of the insertion sites and does not include all insertions in each chromosome. All animals showed the ts1 viral genome insertion sites (VIS) on their chromosomes. Maximum number of insertions were found on chromosomes 10 (26), 12 (32) and 13 (45). Moderate number of insertions were found on chromosomes 1 (10), 2 (13), 5 (18), 7 (13), and 11 (11). Chromosomes 18 and Y did not have any VIS in any of the animals. One mouse (LYM6) had 39 hits on chromosome 13. different degrees. For example, the expression level of Gfi1 in LYM1 is an exaggerated response in expression rather than low or no response to the stimuli showing the importance of this gene in this model. These genes might be in the same pathway leading to lymphoma development in these mice and thus have the same molecular mechanisms for lymphoma development. The same patterns of change in expression for these two genes were also observed in one mouse without lymphoma, N LYM1 suggesting that this mouse might have developed lymphoma if allowed to live longer. The mRNA expression fold increases for gene Irf4 in N LYM1 and N LYM4 and Gfi1 in N LYM1 and N LYM3 in the infected but no lymphoma group compared to the control group may indicate the onset of lymphoma development in these 3 mice before overt clinical manifestations. Although it is possible that we have missed VIS in these mice with this assay, their similar expression patterns compared to that of mice where the VIS were found, suggest that these genes may be involved in some way in the molecular mechanism for lymphoma development.
The change in mRNA expression levels compared to the control group observed for these genes may be due to the VIS and may contribute, in part, to the lymphoma development observed in these mice. This argument is strengthened by the fact that other mice developing lymphoma showed similar patterns of change of mRNA expression of these genes compared to the controls. All other genes tested for mRNA expression levels both with intergenic and intragenic VIS showed unremarkable levels of expression compared to controls at this time. Expression levels tested in the ts1 infected no lymphoma (N LYM) group were also unremarkable in most part except for gene Irf4 with intergenic VIS. Irf4 mRNA gene expression showed 1.5 and 1.7-fold increases in N LYM1 and N LYM4, respectively. Gfi1 mRNA expression was also upregulated in the infected but no lymphoma (N LYM) group by 3.2-fold and 2.8-fold for N LYM1 and N LYM3 respectively, compared to the control group. It would be interesting to see if this mouse might have developed lymphoma if the end time point was set longer. Other genes such as Irf4 and Ccnd1 showed upregulation in only one of the mice with lymphoma. The molecular mechanisms for lymphoma development in these mice may be different compared to the other groups that showed similar patterns of change in their expression. Alternatively a given gene product might be upstream of the pathway showing no change in its expression. Other genes located downstream in the same pathway changed by other VIS might show changes in their expression.
Of the 29 target genes we have identified during this study, transforming acidic coiled-coil protein 3 (Tacc3) gene showed an over 9-fold increase in mRNA expression compared to controls. Overexpression of Tacc3 was related to progression of non-small cell lung cancer (NSCLC) in humans (Jung et al., 2006) . Tacc3 proteins have also been shown to contribute to breast, prostate, multiple myeloma and ovarian cancer (Dhanasekaran et al., 2001; Lauffart et al., 2005; Still et al., 1999a,b) . Jung et al. (2006) recognized that both absence and overexpression of Tacc3 may contribute to cancer production. These investigators proposed that Tacc3 may be important for cancer progression rather than the cause for cancer production. In our study overexpression of Tacc3 may be contributing to progression of lymphoma. Note that in the no lymphoma (NLYMP) group, no significant increase in Tacc3 mRNA expression was observed, suggesting that its function was for cancer progression and not production. In this group, the lymphoma had not yet been produced, Table 4a Intragenic viral integration sites (VIS) The table shows the increase in gene expression by mRNA quantitation by using comparative ddC T method. The effects of viral integration sites (VIS) in two groups of experimental animals were studied in comparison to the control animals. These two experimental groups included animals with infection but no lymphoma (NLYM) and animals with infection and lymphoma (LYM). SEM: Standard error of the mean. Shaded boxes show the genes with significant change in expression levels. This table shows the effect of intragenic VIS. Significant increase of mRNA expression of one gene, i.e., Ahi1 was observed in animals with lymphoma (LYM). None of the other genes showed significant alteration. therefore no progression is underway. All three types of Tacc proteins, i.e. Tacc1, Tacc2 and Tacc3 are components of the centrosomal spindle involved in microtubule stabilization and hematopoietic development. Tacc3 interacts with nuclear transcription factors (Piekorz et al., 2002; Still et al., 2004) . Deficiency of Tacc3 leads to P53 mediated apoptosis. Therefore, overexpression of Tacc3 as it has been observed in our mice may be causing inhibition of apoptosis thus leading to lymphoma.
The other gene with higher than a 2-fold increase in mRNA activity is Aurora kinase A (Aurka). Overexpression of Aurka mRNA has been associated with a number of cancers including head and neck squamous cell carcinoma, esophageal squamous cell carcinoma, glioma, pancreatic cancer, hepatocellular carcinoma and bladder cancer (Jeng et al., 2004; Klein et al., 2004; Li et al., 2003; Reiter et al., 2006; Sen et al., 2002; Tanaka et al., 2005; Tong et al., 2004) . Abnormal centrosome and spindle formation due to increased Aurka mRNA expression has been reported to promote tumor progression (Reiter et al., 2006) and Aurka inhibitors have been proposed for cancer treatment (Andrews, 2005) . Upregulation of Aurka in breast milk mediated lymphoma in our mouse model has a good potential for testing the potential of Aurka inhibitors, which may be applied for therapeutic purposes.
Abelson helper integration site-1 (Ahi1) gene encodes a family of proteins involved in leukemogenesis (Jiang et al., 2004) . Although Ahi1 mRNA expression has been proposed to contribute to the development of human leukemia (Jiang et al., 2004) , possibly a different gene is involved in the process of lymphogenesis (Kim et al., 2003) . The intragenic location of our VIS in Ahi1 makes it quite interesting to understand the interactions of nearby genes at this location for lymphoma. Since the function of Ahi1 protein has not yet been well established, it seems logical to speculate that this protein may be involved in the signal transduction pathway. Our model provides the opportunity to study it further regarding whether an increase in Ahi1 mRNA expression is involved in the development of lymphoma or its progression.
Although retroviral integration into the host genome of a mouse model has been very informative regarding how genomic alteration causes diseases, the process is not the same as observed in human retroviral integration (Lewinski et al., 2006) . For example, HIV's most preferred site of integration is in the active transcription units while murine leukemia virus (MLV) integration occurs near the transcription start sites and CpG islands. HIV can integrate at any time of the cell cycle, while MLV can integrate only after mitosis (Lewinski et al., 2006) . Using a MLV/HIV hybrid, Lewinski et al. (2006) showed distinct favored viral integration in HIV versus MLV. They concluded that viral integrase (IN) is the factor which determines the site of choice of integration. Therefore, further work is needed to understand the similarities and differences between the genomic involvements of murine versus HIV causing malignancy. Our MoMuLV-ts1 model provides an important system for this study of the viral gene integration and its relationship to lymphoma development, caused by natural transmission via breast milk.
Materials and methods

Virus culture and assay
The MoMuLV-ts1 viral stock, TB cells (Thymus-Bone marrow) for viral culture and 15F cells for viral assay were kindly provided by Dr. P. The table shows the increase in gene expression by mRNA quantitation by using comparative ddC T method. The effects of viral integration sites (VIS) in two groups of experimental animals were studied in comparison to the control animals. These two experimental groups included animals with infection but no lymphoma (NLYM) and animals with infection and lymphoma (LYM). SEM: Standard error of the mean. Shaded boxes show the genes with significant change in expression levels. Clear boxes show the highest (Gfi1) and the lowest (Ifng) levels of fold changes in mRNA expression. This table shows the effect of intergenic VIS on mRNA expression of several genes, including Tacc3, Aurka and Vamp8. Tacc3 and Aurka show significant upregulation, while Vamp8 showed significant downregulation. Tacc3 and Aurka were affected in LYM group only, while Vamp8 was downregulated in both LYM and NLYM groups.
K.Y. Wong at the University of Texas M.D. Anderson Cancer Center, Smithville, Texas. Briefly, the ts1 virus was grown in TB cells. TB cells were cultured in Dulbecco Modified Eagle Medium (DMEM) with 6% fetal calf serum, 4% newborn calf serum and 1% penicillin/streptomycin at 37°C until 70-80% confluency. TB cells were then treated with Polybrene in DMEM containing 3% heat inactivated newborn calf serum and 1% penicillin/streptomycin. 1 × 10 6 focus forming units (ffu)/ml of ts1 virus was added to TB cells. The cell suspension with the virus was incubated at 34°C for 40 min. After that, the cells were cultured in fresh DMEM at 34°C for 3 days or until 70-80% confluency. Culture media containing viral particles was removed and filtered through a 0.45 µm filter and stored in 1 ml aliquots at −80°C (Chakraborty et al., 2003) . The 15F cells were grown for viral assay by the same method described above for the TB cells. 9.6 × 10 6 cells/ml were plated onto 60 mm culture plates in Polybrene. Serial dilutions of 0.2 ml viral stock to be assayed were added to the 24 well plates. Next, 0.5 ml of corresponding viral dilutions were transferred to respective 60 mm plates and incubated at 34°C for 40 min. Medium was aspirated and the cells were incubated in fresh DMEM for 3 days at 34°C. Fresh DMEM was added after 3 days and cells were again incubated for 2-3 more days at 34°C and ffu on the plates were counted. A final viral titer of 4.0 × 10 6 ffu/ ml was obtained for the viral stock (Chakraborty et al., 2003) . All experiments involving mice were carried out according to an approved IACUC protocol and under the direct supervision of trained personnel of the Department of Laboratory Animal Medicine at the College of Medicine, Health Science Campus, University of Toledo, OH.
Lymphoma induction in the offspring of ts1 infected mothers
Eighteen timed pregnant BALB/c female mice were purchased from Charles River Co., (Wilmington, Maine). Two to three days after arrival, the 18 females delivered 68 pups at our animal facility. Seventy-two hours after birth, 54 (33 females and 21 males) of these 68 pups were injected intraperitoneally (ip) with 0.1 ml of 4.0 × 10 6 ffu/ml of ts1 virus and designated as infected (experimental) group. The other 14 (11 females and 3 males) pups were injected with 0.1 ml DMEM only, producing an uninfected (control) group. All pups were allowed to reach adulthood. Eleven extra males were purchased from Charles River Laboratories for mating purpose. All females were allowed to mate with control males. The experimental males were euthanized. Thirty-three experimental females produced 99 pups and 11 control females produced 47 pups. Within 6 to 12 h after birth, offspring were allowed to suckle from either control or ts1 infected mothers. These 146 pups were divided into 5 groups (see Table 1 ). Group 1 had 9 pups from control mothers, which suckled from control surrogate mothers. Fortysix group 2 experimental pups suckled from surrogate control mothers. Twenty-nine group 3 experimental pups suckled from ts-1 infected surrogate mothers. Thirty-eight group 4 control pups suckled from ts1 infected surrogate mothers. Twenty-four group 5 experimental pups suckled from their infected biological mothers. PCR were performed using tissue samples from all experimental and control pups to identify ts1 viral genome to determine the infection. Thirteen of 91 pups from groups 3, 4 and 5 developed lymphoma. The lymphoma was scored by using the weight data of the spleen and visual estimation of the lymph nodes (mesenteric) and thymus (photographs published in our previous paper, Duggan et al. (2004) . An increase of 5 to 25-fold of the weight of the spleens was recorded as splenomegaly and increase in the size of the lymph nodes and thymus in combination with the increase in spleen weight was considered as the indication of lymphoma. Tissues from the spleens and lymph nodes were collected from all animals for analyses of viral genome integration sites. However for the current study, only tissues from spleens were used. Tissues from 5 control animals, 4 with infection but no lymphoma and 6 with infection and lymphoma were used for I-PCR and mRNA expression studies.
Inverse-PCR (I-PCR) and DNA cloning
Spleens and lymph nodes from infected mice that developed lymphoma and from infected mice that did not develop lymphoma Table 3 , using comparable ddC T method. Ahi1, Tacc3 and Aurka showed significant increase in mRNA expression.
were examined for viral integration sites. High molecular weight genomic DNA was extracted from the tissues using Qiagen Genomic DNA Purification kit (Qiagen, Valencia, CA.), digested with BamH1, purified and ligated using T4 ligase for I-PCR (Li et al., 1999) . Primary PCR was performed using a set of inverse primers [forward 1AF: CAG ACA CAG ATA AGT TGC TGG CCA G (211-235) and reverse 1AR: AAG ACG CTT GGA GAT TTG GTT AGA G (1872-1896) designed from MoMuLV ts1 sequence at the 5′end products of BamH1 digest. Numbers in the parenthesis indicate positions of bases on MoMuLV ts1 sequence (Mouse Genome Database). The solution consisted of 20 pmol each for the inverse primers, 2 μl DNA template, 500 μM dNTPs, 1.3 U of Expand Long Template Polymerase and 5 μl Expand Buffer System 3 (Roche Diagnostics Corp., Indianapolis, IN) and the volume was brought to 50 μl with distilled water. Thermal cycling conditions were as follows: 94°C for 2 min followed by 10 cycles of 94°C for 10 s, 55°C for 30 s and 68°C for 10 min; 25 cycles of 94°C for 10 s, 55°C for 30 s and 68°C for 10 min (auto-extension 20 sec per cycle) followed by a final extension at 68°C for 10 min. The secondary PCR reaction was performed using primary PCR product as template and using the same parameters as in primary PCR except with nested (secondary) primers in place of primary primers [forward 2AF: AGA CCA CGA TTC GGA TGC AAA CAG (61-84) and reverse 2AR: GAG AGA TGA GCA AGC TAT TGG CCA C (2035-2059)]. PCR products were run on a gel, bands were cut out, purified and cloned using TOPO TA cloning kit (Invitrogen, Calsbad, CA) following the manufacturer's instructions. Colonies with viral inserts were identified and analyzed (see Table 2 ). PCR products cloned ranged from 800 b to 2 kb, which was expected to contain approximately 500 to 1800 bases of host genomic sequence. Colonies were selected and purified with Qiagen Miniprep kit (Qiagen, Valencia, CA) and sequenced at MWG-Biotech (MWGBiotech Inc., High Point, NC).
Quantitative reverse transcriptase-PCR (qRT-PCR)
The quantitative real-time RT-PCR technique was used to examine differential expression of selected candidate genes. First-strand cDNAs were reverse transcribed from total RNA (5 µg/reaction) using Oligo (dT) 20 as primers and SuperScript III (Invitrogen). Gene-specific primers were designed using Primer Express software (version 1.5; Applied Biosystems ABI, Foster City, CA) to amplify 75-100 bp PCR products. Expression of GAPDH, a "house keeping" gene was used to normalize the data. qRT-PCR was performed essentially as described by Lee et al. (2005) using the iCycler thermal cycling instrument and MyiQ SingleColor real-time PCR Detection System software (BioRad, Hercules, CA). Specifically, real-time PCR was performed on three replicates per sample using IQ SYBR Green Supermix kit (BioRad, Hercules, CA) on 5 µl of template cDNA of varying dilutions with 1 µl of gene-specific 3′ and 5′ primer mixtures (2.5 µM solution) optimized for a given primer pair per 25 µl reaction. The reaction mixture contained 12.5 µl of 2× master mix (100 mM KCl, 40 mM Tris-HCl, pH 8.4, 6 mM MgCl 2 , 0.4 mM dNTPs, 50 units/ml iTaq DNA polymerase, 20 nM SYBR Green (BioRad, Hercules, CA)), 12.5 µl of cDNA at appropriate dilutions plus primer mixtures and distilled H 2 O, run on the following thermocycler programs: 95°C for 3 min followed by 40 cycles of 95°C for 30 s, 60°C for 30 s 0.5°C increments starting at 55°C for 80 cycles. Melt-curve analysis was performed immediately after amplification to confirm amplification of a single PCR product. "No-template" controls were included to ensure amplification specificity. RNA expression levels were calculated for each gene using comparative ddCt method using house keeping gene, GAPDH expression levels. Gene expressions are presented as relative values and expressed as the "fold change".
All statistical analysis was performed by using Statistical Package for the Social Sciences (SPSS) software. Student's t-test was used to test the equivalence of mean gene expression between control and ts1 infected no lymphoma (N LYM) or ts1 infected with lymphoma (LYM) development. A p value of b0.05 was used to indicate a statistically significant difference.
